Encompass Health Corporation — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 — 27 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.

Recent · last 8 quarters Future · next 8 quarters

Est. = analyst consensus (Finnhub)

Report date	Fiscal Q	Est. Revenue	Est. EPS	Call Time	In
2026-04-30	Q1 2026	$1.58B	$1.51	AMC	in 3d
2026-08-03	Q2 2026	$1.59B	$1.49	AMC	in 98d

Forward dates from Finnhub. Smaller filers and foreign listings sometimes publish dates only ~6 weeks before the report — check back closer to the next anticipated quarter.

Last earnings · FY2025 (Q4)

Revenue

$1.54B

↑+9.9% +$140M YoY

Net Income

$146M

↑+20.8% +$25M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Go deeper

EHC Sankey — flow of dollars

See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.

Open Sankey

EHC Key Metrics — EPS, ROE, ROIC

10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.